VR Logo

Laurus Labs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2005

Chairman: Malempati Venugopala Rao

Managing Director: --

Group: --

Listing: NSE: LAURUSLABS, BSE: 540222

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.lauruslabs.com

Key Facts

Market cap: R 19,840.87 Cr

Revenue (TTM): R 3,681.89 Cr

Earnings (TTM): R 597.68 Cr

Cash: R 1.74 Cr

Total Debt: R 1,056.88 Cr

Promoters' ownership: 28.73%

Liquidity: High

52 Week range: R 59.00 - 377.45

Face value: R2.00

Shares outstanding: 53,66,02,385

9 Years Aggregate:

  • CFO: 1,685.08 Cr
  • EBITDA: 2,716.60 Cr
  • Net Profit: 1,117.25 Cr

Stock Performance

Time Period Laurus Labs S&P BSE Healthcare S&P BSE Mid Cap
YTD4.791.635.37
1 month12.684.246.60
3 months17.1812.1230.65
1 Year352.6759.8121.91
3 Years50.2513.871.40
5 Years--7.0712.80
10 Years--13.0010.09
As on 15-Jan-2021
Year Laurus Labs S&P BSE Mid Cap S&P BSE Healthcare
2020379.5019.8761.45
2019-6.06-3.05-3.55
2018-29.95-13.31-5.89
201712.9048.130.49

Review & Analysis